PPAR gamma/delta dual agonists (GlaxoSmithKline)

N/A

Report date: 2025/03/20 10:07:09
NME

Base Information

Drug NamePPAR gamma/delta dual agonists (GlaxoSmithKline)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersPeroxisome proliferator-activated receptor delta agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsObesityHyperlipidemiasDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsObesityHyperlipidemiasDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A